IRCT20130610013612N12招募中未知
Evaluation of the effect of Empagliflozin on blood glucose, BMI, HbA1c and insulin dose in patients with type 1 diabetes
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 30 years（—）
- 性别
- All
入选标准
- •Type 1 diabetes
- •Age over 18 years and less than 30 years
- •Able to measure blood sugar daily
- •Be able to measure daily urine ketones
- •HbA1C between 7.5% - 8.5%
排除标准
- •Kidney failure
- •Active infection
- •urinary infection
- •Cortone use
研究者
相似试验
招募中
3 期
Effect of empagliflozin on blood pressure, cardiovascular events, mortality and renal parametersIRCT20190911044744N3Yazd University of Medical Sciences50
招募中
3 期
Investigating the effect of empagliflozin on blood sugar control, edema, electrolytes and hypertensioIRCT20130812014333N217Kermanshah University of Medical Sciences134
招募中
3 期
The effect of empagliflozin on improvement of hematopeosis in diabetic cardiovascular patientIRCT20190806044451N1Zanjan University of Medical Sciences90
招募中
不适用
Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate LevelsHematocrit ChangeCardiovascular PreventionEmpagliflozinSGLT2-InhibitorsTissue OxygenationNCT06284850Aristotle University Of Thessaloniki40
已完成
3 期
Effect of Empagliflozin in prevention of kidney stone parametersIRCT20211203053261N2Hamedan University of Medical Sciences138